← Every applicant
Abon Pharms LLC FDA Approvals
3 new drug approvals and 0 device clearances on file. This applicant is not matched to a listed company.
Newest first
A new drug approval is an original application; a 510(k) is a device shown equivalent to one already sold.
| Product |
|---|
| ERYTHROMYCINNew drugSep 23, 2025TABLET, ORAL |
| VENLAFAXINE HYDROCHLORIDENew drugFeb 7, 2025TABLET, EXTENDED RELEASE, ORAL |
| SUCRALFATENew drugMar 21, 2024SUSPENSION, ORAL |